LN6023

N/A

Report date: 2022/09/28 10:43:22
NME

Base Information

Drug NameLN6023
Drug Alias NameLN-6023
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X-C chemokine receptor type 7 agonists
TargetsC-X-C chemokine receptor type 7
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEberhard Karls University Tübingen
China Registration ClassN/A

Develop Information

Active CompaniesEberhard Karls University Tübingen
Inactive CompaniesN/A
Active IndicationsThrombosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A